Coagulopathy, injury severity and bleeding progression but not prior antiplatelet and anticoagulation therapies drive prognosis in patients with moderate to severe traumatic brain injury

IntroductionAntiplatelet and anticoagulant therapies complicate the management and outcomes of traumatic brain injury (TBI) patients. This study evaluates clinical profiles and short-term outcomes focusing on prior antihemostatic therapy and tranexamic acid (TXA) use.Patients and methodsWe analyzed...

Descripció completa

Dades bibliogràfiques

Autors principals:	Franziska Lieschke, Daniel T. Marggrander, Konstantin D. Kohlhase, Daniel Touma, Jan Hendrik Schaefer, Sarah C. Reitz, Juergen Konczalla, Cora R. Schindler, Christian Grefkes, Ferdinand O. Bohmann
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-07-01
Col·lecció:	Frontiers in Neurology
Matèries:	traumatic brain injury anticoagulation (dual) antiplatelet therapy intracranial hemorrhage demographic change falls
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1592583/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!